Press Release
Category Added in a WPeMatico Campaign
-
Hudson Labs Launches Co-Analyst — High-Precision AI for Institutional Equity Research
TORONTO–(BUSINESS WIRE)–Hudson Labs Announces Launch of Co-Analyst AI Platform Hudson Labs, a financial AI company founded in 2019, today announced…
Read More » -
Abdera Therapeutics Presents Initial Phase 1 Clinical Data on ABD-147, a Next-generation DLL3-targeting Radiopharmaceutical Therapy, at IASLC 2025 World Conference on Lung Cancer
Data from first patient cohort provide human proof-of-concept and support continued dose escalation in patients with small cell lung cancer…
Read More » -
Incubeta Acquires RocketSource to Expand Human-Centered AI Capabilities
Acquisition expands Incubeta’s AI offerings, combining behavioral science and performance expertise to help marketers drive sustainable growth LONDON–(BUSINESS WIRE)–Incubeta, a…
Read More » -
Jetson Debuts First Smart Heat Pump that Automatically Monitors Air, Energy, and System Health for Half the Cost
Jetson is the only company that designs, sells, and installs its own home central heat pump system, offering homeowners a…
Read More » -
Black Construction-Tutor Perini JV Awarded $181.8 Million Guam Defense System Project
LOS ANGELES–(BUSINESS WIRE)–#newaward–Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil, building and specialty construction company, announced today that…
Read More » -
As AI Reshapes Hiring, PARWCC Launches Interview Institute to Professionalize Coaching in the Job Market’s Most Critical Moment
ST. PETERSBURG, Fla., Sept. 9, 2025 /PRNewswire/ — Artificial intelligence is changing how people get hired. From AI-generated résumés to automated…
Read More » -
TRML Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Tourmaline Bio, Inc. Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Tourmaline Bio, Inc. (NASDAQ:…
Read More » -
Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib at the IASLC 2025 World Conference on Lung Cancer
Updated efficacy and safety data to be presented from the REZILIENT1 trial of zipalertinib from the cohort of patients with…
Read More »